Sencilia key facts
- Developer of intravenous line infusion monitoring services intended to improve patient safety in neonatal and pediatric intensive care.
- It has raised $860K; the latest was Early Stage VC in Sep 2025.
- Notable investors include Imec.istart, Draper University, RUG Ventures, Triade Investment, Future Tech Ventures — 14 tracked in total.
- Status: Privately Held (backing).
Who backs Sencilia
14+- ·The complete investor list: 14 names
- ·Watch Sencilia: the Monday email on marks, rounds and moves
Sencilia funding rounds
No funding rounds for Sencilia are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Sencilia investors
14 investors are on record for Sencilia, including Imec.istart, Draper University, RUG Ventures and Triade Investment.
About Sencilia
Developer of intravenous line infusion monitoring services intended to improve patient safety in neonatal and pediatric intensive care. The company specializes in offering flow management automation technology, diagnosing respiratory disorders, and providing flow sensors and underwater sensing systems, enabling the healthcare, robotics, water, and energy industries to improve the accuracy of fluid balance and mitigate nurse workload.
- Sector
- Information Technology
- HQ
- Groningen, Netherlands
- Founded
- 2021
- Employees
- 8
- Website
- sencilia.nl/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Sencilia doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.